2017 Forecast - Hormone Refractory Prostate Cancer Global Market, Industry Size, Share, Analysis and Opportunities to 2023
Latest industry research report on Hormone Refractory Prostate Cancer Market. Hormone Refractory Prostate Cancer (HRPCA) or Castrate-Resistant Prostate Cancer (CRPC), a type of prostate cancer that typically recurs after having hormonal therapy, is now under the spotlight in prostate cancer market. Due to the high unmet clinical need associated with limited survival periods, intensifying HRPCA prevalence and fast-emerging treatment modifications, the global HRPCA market is poised to witness an unprecedented growth.
View full press release